Proto Script Pharmaceutical (PSCR) Stock Analysis & Winston Score

Winston Score History

Proto Script Pharmaceutical Corp. is a small specialty company that provides pharmaceutical compounding and related services. Compounding means mixing or preparing custom medications tailored to individual patients when standard commercial drugs do not meet their needs. The company serves patients, healthcare providers, and pharmacies, operating within the specialty business services segment of the industrials sector.

The company generates revenue primarily through service fees and product sales tied to its compounding operations, which explains its relatively high gross margin of 71.5%. However, it is currently spending more than it earns at the operating level, reflected in its negative operating margin of nearly 38%, meaning it is not yet profitable on a day-to-day basis. The main risk the business faces is regulatory scrutiny, as pharmaceutical compounding is closely monitored by the FDA and state pharmacy boards, and any compliance failures could significantly disrupt operations or limit its ability to grow.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+17.8% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

<−1,000% YoY

YoY Growth Rate

Earnings declining

Insider Activity

8.8%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$0 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Proto Script Pharmaceutical has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

84.8%

Premium pricing power — 84.8% gross margin

Profit after running costs

Operating Margin

-33.9%

Losing money on operations — -33.9%

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+75.2%

Fast-growing sales (+75.2% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-55.7%

Burning cash (-55.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial